Trial Information

Summary: Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer

A Randomized, Parallel Group, Open-Label, Active Controlled, Multicenter Phase III Trial of Patupilone (EPO906) Versus Pegylated Liposomal Doxorubicin in Taxane/Platinum Refractory/Resistant Patients With Recurrent Epithelial Ovarian, Primary Fallopian or Primary Peritoneal Cancer

Patient Inclusion Criteria

• 18 years of age or older
• Confirmed diagnosis of ovarian cancer, primary fallopian or primary peritoneal cancer
• Had no more than three previous taxane/platinum-based combination chemotherapy regimen, last regimen must be platinum based
• Cancer that did not respond, or re-occurred less than 6 months after last chemotherapy

Patient Exclusion Criteria

• Have an unresolved bowel obstruction
• Have had previous chemotherapy within 3 weeks
• Recovering from any surgery for any cause

Contact: Cathy Spears, Director Research Oncology St. Francis Hospital and Health Centers 1500 N Albany Street, Suite 1001 Beech Grove, IN 46107 Telephone: 317-782-7819 Fax: 317-782-7828 Email: Profile Page: St. Francis Hospital and Health Centers, Beech Grove, IN

Maps by Google



If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:	Please Select Clinical Trial Participation Website Feedback Other
Name:
Address:
City:
State:
*Zip:
*Country:	Please Select ------------------------------ France Germany Japan Switzerland United Kingdom United States ------------------------------ Afghanistan Albania Algeria American Samoa Amer.Virgin Is. Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bahrain Bhutan Bolivia Bosnia and Herzegowina Botswana Bouvet Island Brazil Brit.Ind.Oc.Ter Brit.Virgin Is. Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Islnd Coconut Islands Columbia Comoros Congo Cook Islands Costa Rica Croatia Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Faeroe Falkland Islnds Fiji Finland France French Polynesia French Guiana Gabon Gambia Georgia Germany Ghana Gibraltar Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Heard Islands and McDonald Islands Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Ivory Coast Jamaica Japan Jordan Kazakhstan Kenya Kirghistan Kiribati Kuwait Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islnds Martinique Mauretania Mauritius Mexico Micronesia Minor Outl.Isl. Moldavia Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Islands Norfolk Island North Korea Northern Marianas Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Islands Poland Portugal Puerto Rico Qatar Réunion Rumania Russia Rwanda San Marino São Tomé and Príncipe Saudi Arabia Senegal Serbia and Montenegro Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka St. Helena St. Lucia St. Kitts and Nevis St. Pierre and Miquelon St. Vincent and the Grenadines stateless Samoa Sudan Suriname Svalbard Swaziland Sweden Switzerland Syria Tadzhikistan Taiwan Tanzania Thailand Togo Tokelau Islands Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Kingdom United States Uruguay United Arab Emirates Uzbekistan Vanuatu Vatican City Venezuela Vietnam Wallis and Futuna Yemen Zaire Zambia Zimbabwe
Phone:
*Email address:
Message:




Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: July 29, 2008 at 2:55:44 PM